SB 1625

  • Illinois Senate Bill
  • 102nd Regular Session
  • Introduced in Senate
  • Senate
  • House
  • Governor

Pharmacy-Price Disclosure

Abstract

Amends the Pharmacy Practice Act. Removes a provision limiting consumers to 10 requests for disclosure of the current usual and customary retail price of prescription drugs or medical devices for which the person making the request has a prescription. Provides that a pharmacy must post a notice informing customers that they may request, in person or by telephone, the current usual and customary retail price of any brand or generic prescription drug or medical device that the pharmacy offers for sale to the public. Provides that a pharmacist or his or her authorized employee must disclose to the consumer at the point of sale the current pharmacy retail price for each prescription medication the consumer intends to purchase. If the consumer's cost-sharing amount for a prescription exceeds the current pharmacy retail price, the pharmacist or his or her authorized employee must disclose to the consumer that the pharmacy retail price is less than the patient's cost-sharing amount.

Bill Sponsors (5)

Votes


No votes to display

Actions


Jan 10, 2023

Senate

Session Sine Die

Apr 16, 2021

Senate

Rule 3-9(a) / Re-referred to Assignments

Mar 24, 2021

Senate

Added as Chief Co-Sponsor Sen. Julie A. Morrison

Senate

Postponed - Licensed Activities

Mar 17, 2021

Senate

Added as Co-Sponsor Sen. Mattie Hunter

Mar 16, 2021

Senate

Added as Co-Sponsor Sen. Emil Jones, III

Senate

Added as Co-Sponsor Sen. Adriane Johnson

Mar 09, 2021

Senate

Assigned to Licensed Activities

Feb 26, 2021

Senate

Filed with Secretary by Sen. Doris Turner

Senate

Referred to Assignments

Senate

First Reading

Bill Text

Bill Text Versions Format
Introduced HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.